Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by johnny007on Apr 09, 2021 6:57pm
121 Views
Post# 32971517

RE:RE:RE:RE:RE:RE:Extreme Dissapointement in Botched Launch

RE:RE:RE:RE:RE:RE:Extreme Dissapointement in Botched LaunchI am the first one here who found the actual target company.
I am sure the dear analyst and broker did his job as well, right after the NR.

Please feel free to look into my message history,
you will see proper DD and also periods of bullishness for this company.
Yes, of course, I did mature my viewpoint here.

Instead of trying to silent me with your tone,
perhaps you could also DD the situation and target?

Ask some questions to SZLS and SEEK perhaps:

What will SZLS acquire for 23M shares?
The 1-2 subs of SEEK GROUP or are we talking reverse merger
of a 6 employee company with SZLS here?

What is SEEK's current financial situation?
Still like 2019?

What is the cash flow and what are the annual losses?

When will SZLS provide details about the target?
Within 4 weeks?
<< Previous
Bullboard Posts
Next >>